Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Other Non-Current Liabilities (2020 - 2022)

Aura Biosciences filings provide 3 years of Other Non-Current Liabilities readings, the most recent being $67000.0 for Q2 2022.

  • Quarterly Other Non-Current Liabilities changed N/A to $67000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $67000.0 through Jun 2022, changed N/A year-over-year, with the annual reading at $83000.0 for FY2021, 15.28% up from the prior year.
  • Other Non-Current Liabilities hit $67000.0 in Q2 2022 for Aura Biosciences, down from $127000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $127000.0 in Q1 2022 and bottomed at $67000.0 in Q2 2022.
  • Average Other Non-Current Liabilities over 3 years is $84000.0, with a median of $72000.0 recorded in 2020.
  • Peak annual rise in Other Non-Current Liabilities hit 15.28% in 2021, while the deepest fall reached 15.28% in 2021.
  • Aura Biosciences' Other Non-Current Liabilities stood at $72000.0 in 2020, then increased by 15.28% to $83000.0 in 2021, then fell by 19.28% to $67000.0 in 2022.
  • Per Business Quant, the three most recent readings for AURA's Other Non-Current Liabilities are $67000.0 (Q2 2022), $127000.0 (Q1 2022), and $83000.0 (Q4 2021).